Vanhoefer U - Search Results

1

PAK-104P, a pyridine analogue, reverses paclitaxel and doxorubicin resistance in cell lines and nude mice bearing xenografts that overexpress the multidrug resistance protein.

Vanhoefer U, Cao S, Minderman H, Tóth K, Scheper RJ, Slovak ML, Rustum YM. Vanhoefer U, et al. Clin Cancer Res. 1996 Feb;2(2):369-77. Clin Cancer Res. 1996. PMID: 9816180

2

A unique human ovarian carcinoma cell line expressing CD34 in association with selection for multidrug resistance.

Minderman H, Vanhoefer U, Toth K, Minderman MD, Rustum YM. Minderman H, et al. Among authors: vanhoefer u. Cancer. 1996 Dec 1;78(11):2427-36. Cancer. 1996. PMID: 8941015

3

Carbamoylation of glutathione reductase by N,N-bis(2-chloroethyl)-N- nitrosourea associated with inhibition of multidrug resistance protein (MRP) function.

Vanhoefer U, Yin MB, Harstrick A, Seeber S, Rustum YM. Vanhoefer U, et al. Biochem Pharmacol. 1997 Mar 21;53(6):801-9. doi: 10.1016/s0006-2952(97)00010-5. Biochem Pharmacol. 1997. PMID: 9113101

4

Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multidrug-resistant human tumor cells.

Vanhoefer U, Voigt W, Hilger RA, Yin MB, Harstrick A, Seeber S, Rustum YM. Vanhoefer U, et al. Oncol Res. 1997;9(9):485-94. Oncol Res. 1997. PMID: 9495454

5

Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP).

Vanhoefer U, Cao S, Harstrick A, Seeber S, Rustum YM. Vanhoefer U, et al. Ann Oncol. 1997 Dec;8(12):1221-8. doi: 10.1023/a:1008290406221. Ann Oncol. 1997. PMID: 9496387 Free article.

6

d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.

Vanhoefer U, Cao S, Minderman H, Toth K, Skenderis BS 2nd, Slovak ML, Rustum YM. Vanhoefer U, et al. Clin Cancer Res. 1996 Dec;2(12):1961-8. Clin Cancer Res. 1996. PMID: 9816155

7

DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux.

Minderman H, Vanhoefer U, Toth K, Yin MB, Minderman MD, Wrzosek C, Slovak ML, Rustum YM. Minderman H, et al. Among authors: vanhoefer u. Cytometry. 1996 Sep 1;25(1):14-20. doi: 10.1002/(SICI)1097-0320(19960901)25:1<14::AID-CYTO2>3.0.CO;2-E. Cytometry. 1996. PMID: 8875050 Free article.

8

Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors.

Rustum YM, Harstrick A, Cao S, Vanhoefer U, Yin MB, Wilke H, Seeber S. Rustum YM, et al. Among authors: vanhoefer u. J Clin Oncol. 1997 Jan;15(1):389-400. doi: 10.1200/JCO.1997.15.1.389. J Clin Oncol. 1997. PMID: 8996166 Review.

9

Novel cellular determinants for reversal of multidrug resistance in cells expressing P170-glycoprotein.

Yin MB, Guo B, Voigt W, Vanhoefer U, Gibbs JF, Skenderis BS, Frank C, Wrzosek C, Rustum YM. Yin MB, et al. Among authors: vanhoefer u. Biochim Biophys Acta. 1998 Mar 5;1401(3):265-76. doi: 10.1016/s0167-4889(97)00137-7. Biochim Biophys Acta. 1998. PMID: 9540817 Free article.

10

Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell lines.

Vanhoefer U, Müller MR, Hilger RA, Lindtner B, Klaassen U, Schleucher N, Rustum YM, Seeber S, Harstrick A. Vanhoefer U, et al. Br J Cancer. 1999 Dec;81(8):1304-10. doi: 10.1038/sj.bjc.6694384. Br J Cancer. 1999. PMID: 10604726 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters